Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 403

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 403
---
 and Directors as a group (8 Total)(9)

    3,210,472

    7.4
    %

    Greater than 5% Stockholders

    Vijay Patel(10)

    12,364,430

    25.7
    %

    CA Patel F&F Investments, LLC (11)

    2,572,582

    5.8
    %

    KP Biotech Group, LLC(12)

    2,572,582

    5.8
    %

    Samir Patel(13)

    2,466,377

    5.7
    %

    Charles Theofilos, M.D. (14)

    2,506,321

    5.7
    %

*Represents beneficial ownership of less than 1%.

(1)Except as otherwise indicated, the address of each beneficial owner is c/o TuHURA Biosciences, Inc., 10500 University Center Dr., Suite 110, Tampa, FL 33612.

(2)Consists of (i) 2,323,307 shares of our common stock and (ii) 469,268 options to purchase our common stock held directly by Dr. Bianco exercisable within 60 days after the Beneficial Ownership Date.

111

(3)Consists of 295,440 options to purchase our common stock held directly by Mr. Dearborn exercisable within 60 days after the Beneficial Ownership Date.

(4)Consists of 62,891 options to purchase our common stock held directly by Mr. Ng exercisable within 60 days after the Beneficial Ownership Date.

(5)Consists of 27,106 options to purchase our common stock held directly by Dr. List exercisable within 60 days after the Beneficial Ownership Date.

(6)Consists of 27,106 options to purchase our common stock held directly by Dr. Manuso exercisable within 60 days after the Beneficial Ownership Date.

(7)Consists of (i) 1,823 shares of our Common Stock and (ii) 3,531 shares held directly by Mr. Hoffman issuable upon the exercise of vested stock options within 60 days of the Beneficial Ownership Date.

(8)Dr. Tendler was appointed to our board of directors effective March 10, 2025. 

(9)On December 19, 2023 TuHURA and Dennis Yam